SacredBod's longer take on Citrus Bergamot (38%) — context the structured blocks above don't capture.
About Citrus Bergamot (38%)
Citrus Bergamot (38%) is a cardiovascular supplement used to support cardiovascular and circulatory health. Bergamot polyphenols for cholesterol. It is available in capsule form and dosed for adults in India and internationally. As a western-tradition entry in the SacredBod catalog, it is positioned as a single-ingredient option that can be used on its own or layered into a broader protocol. Citrus Bergamot (38%) works through the mechanisms characteristic of its class — see the mechanism and research sections for detail. It primarily acts on the heart, blood vessels, and effects are dose-dependent, typically becoming measurable within 4-12 weeks for measurable cardiovascular markers. Consistency matters more than dose size for this category.
Evidence
Citrus Bergamot (38%) carries an evidence grade of C in the SacredBod catalog, reflecting emerging human evidence for cardiovascular and circulatory health. Bergamot polyphenols for cholesterol. Benefits are cumulative rather than immediate, typically becoming noticeable within 4-12 weeks for measurable cardiovascular markers, and individual response varies.
Dosing
A typical dose is 500 mg, taken with food, usually in the morning. Start at the lower end, assess tolerance, and stay consistent; more is not automatically better.
Cautions
Pregnant or nursing women without clinician oversight. People on prescription medication affecting the same pathway should consult a doctor before combining. Side effects are uncommon at recommended doses but mild GI upset can occur when starting.
Who it’s for
Adults looking to address high blood pressure, poor circulation, high cholesterol. Particularly relevant for people who prefer a targeted single ingredient and who have ruled out an underlying condition that needs medical care first.
As part of the Cardiovascular category, Citrus Bergamot (38%) can be used on its own or layered into a broader protocol — see the Goes with panel for evidence-aligned pairings.